Genomics

Dataset Information

0

TAS-102, Irinotecan, and Bevacizumab in Pre-treated Metastatic Colorectal Cancer (TABAsCO), A Phase II Clinical Trial. ClinicalTrials.gov NCT04109924


ABSTRACT: TAS-102, Irinotecan, and Bevacizumab in Pre-treated Metastatic Colorectal Cancer (TABAsCO), A Phase II Clinical Trial. ClinicalTrials.gov NCT04109924

PROVIDER: PRJNA1152270 | ENA |

REPOSITORIES: ENA

Dataset's files

Source:
Action DRS
SRR30363000_1.fastq.gz Fastqsanger.gz
SRR30363000_2.fastq.gz Fastqsanger.gz
SRR30362989_1.fastq.gz Fastqsanger.gz
SRR30362989_2.fastq.gz Fastqsanger.gz
SRR30362990_1.fastq.gz Fastqsanger.gz
Items per page:
1 - 5 of 68

Similar Datasets

2024-08-26 | GSE275628 | GEO
2023-03-31 | GSE226221 | GEO
| 2317842 | ecrin-mdr-crc
| PRJNA939181 | ENA
| 2741301 | ecrin-mdr-crc
2013-01-15 | E-MTAB-951 | biostudies-arrayexpress
| 92106 | ecrin-mdr-crc
| S-EPMC8637322 | biostudies-literature
| 14404 | ecrin-mdr-crc
| 2610898 | ecrin-mdr-crc